Literature DB >> 1555694

Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels.

T Tanbo1, P O Dale, O Lunde, N Norman, T Abyholm.   

Abstract

OBJECTIVE: To test the ovarian reserve in a high-risk population before controlled ovarian hyperstimulation for in vitro fertilization (IVF).
DESIGN: A prospective study comparing the outcome of a clomiphene citrate (CC) challenge test to the outcome of subsequent IVF cycles.
SETTING: Unit for assisted reproductive technology in a university hospital. PATIENTS, PARTICIPANTS: Ninety-one infertile women with an age of 35 years or more, who had previous ovarian surgery or who had been diagnosed with ovarian endometriosis. MAIN OUTCOME MEASURE: Relate follicle-stimulating hormone (FSH) levels before and after CC to frequency of cancellation of an IVF cycle because of a poor follicular response.
RESULTS: Twenty-one patients had elevated basal levels of FSH. Thirty-seven patients, including 20 with high basal levels, showed an excessive FSH response to CC with an FSH level after CC above the 95% confidence limit. Clomiphene citrate-stimulated FSH levels correlated better than basal levels with response to controlled ovarian hyperstimulation. An excessive FSH response to CC predicted a poor response outcome of subsequent controlled ovarian hyperstimulation for IVF with 85% accuracy.
CONCLUSION: Follicle-stimulating hormone response to CC predicts subsequent follicular response to controlled ovarian hyperstimulation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1555694     DOI: 10.1016/s0015-0282(16)54965-6

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  Cycle characteristics of day 3 embryo transfers with 4-cell embryos only.

Authors:  G Ertzeid; R Storeng; T Tanbo; P O Dale; S Bjercke; T Abyholm
Journal:  J Assist Reprod Genet       Date:  2003-09       Impact factor: 3.412

2.  Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF.

Authors:  D J Hendriks; F J Broekmans; L F J M M Bancsi; C W N Looman; F H de Jong; E R te Velde
Journal:  J Assist Reprod Genet       Date:  2005-02       Impact factor: 3.412

3.  The poor-responder patient in an in vitro fertilization-embryo transfer program.

Authors:  Z Ben-Rafael; D Feldberg
Journal:  J Assist Reprod Genet       Date:  1993-02       Impact factor: 3.412

4.  The prognostic value of age and follicle-stimulating hormone levels in women over forty years of age undergoing in vitro fertilization.

Authors:  A H Watt; A T Legedza; E S Ginsburg; R L Barbieri; R N Clarke; M D Hornstein
Journal:  J Assist Reprod Genet       Date:  2000-05       Impact factor: 3.412

Review 5.  Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet.

Authors:  S J Fasouliotis; A Simon; N Laufer
Journal:  J Assist Reprod Genet       Date:  2000-08       Impact factor: 3.412

6.  Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.

Authors:  F J Huang; S Y Chang; M Y Tsai; F T Kung; J F Wu; H W Chang
Journal:  J Assist Reprod Genet       Date:  2001-02       Impact factor: 3.412

7.  Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests and predictors of poor ovarian response in IVF.

Authors:  Mehmet Erdem; Ahmet Erdem; Rifat Gursoy; Kutay Biberoglu
Journal:  J Assist Reprod Genet       Date:  2004-02       Impact factor: 3.412

8.  A comparison of the efficacy and safety of traditional Chinese medicine in preconditioning patients with diminished ovarian reserve that would undergo In Vitro fertilization: A network meta-analysis protocol.

Authors:  Xiuyun Qin; Yongping Gong; Feng Yu; Jiangquan Song; Shuangqian Dong; Ruoqian Zhang; Jianwei Zhang
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.